Welcome to our dedicated page for Restart Life news (Ticker: NMLSD), a resource for investors and traders seeking the latest updates and insights on Restart Life stock.
Restart Life (NMLSD) is a Canadian life sciences innovator developing cognitive health products through strategic production partnerships and scientific research. This news hub provides investors and industry observers with essential updates on the company's operational milestones and market positioning.
Access timely announcements spanning product innovations, joint ventures like the Brain Balls Inc. collaboration, and manufacturing developments with its Canadian co-packing partner. Our curated feed includes earnings disclosures, leadership updates, and quality assurance initiatives that demonstrate the company's commitment to clean-label wellness solutions.
Bookmark this page for centralized access to Restart Life's verified press releases and financial communications. Monitor key developments in cognitive health product development and production excellence within the competitive life sciences sector.
Restart Life Sciences Corp (CSE: HEAL, OTC: NMLSD) has secured exclusive licensing rights to four health-related trademarks under a 5-year agreement, renewable for another 5 years. The deal includes a nominal $1 licensing fee and royalty structure of 5% on gross sales up to $1,000,000, reducing to 2.5% for sales exceeding $1,000,000.
The agreement, made with a company controlled by one of Restart Life's directors, includes a previously revenue-generating health-care brand that operated on Amazon. Royalties can be paid in cash, company common shares, or a combination of both. Both parties have agreed to negotiate the purchase of the licensed trademarks at the end of the term.
The transaction is exempt from formal valuation requirements and minority shareholder approval requirements under Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions.
Restart Life Sciences Corp. (NMLSD) has secured a strategic production partnership with a Canadian co-packer for manufacturing their Brain Balls product line. The co-packer, known for healthy cereals, will handle raw ingredients, packaging, and shipping from their British Columbia facility.
This partnership follows the December 13, 2024 joint venture with Brain Balls Inc. to develop health-focused products targeting cognitive performance and brain health. The company also completed a debt settlement of $118,476.75 by issuing 1,579,689 units at $0.075 per unit, each including one common share and one warrant exercisable at $0.10 for 12 months.
Additionally, Restart Life granted 1,830,000 stock options and 3,095,000 RSUs to officers, directors, and consultants, exercisable at $0.10 per share with a two-year term.
